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A quantitative comparison of 
cytosolic delivery via different 
protein uptake systems
Wouter P. R. Verdurmen  1,2, Marigona Mazlami1 & Andreas Plückthun  1
Over many years, a variety of delivery systems have been investigated that have the capacity to 
shuttle macromolecular cargoes, especially proteins, into the cytosol. Due to the lack of an objective 
way to quantify cytosolic delivery, relative delivery efficiencies of the various transport systems 
have remained unclear. Here, we demonstrate the use of the biotin ligase assay for a quantitative 
comparison of protein transport to the cytosol via cell-penetrating peptides, supercharged proteins and 
bacterial toxins in four different cell lines. The data illustrate large differences in both the total cellular 
internalization, which denotes any intracellular location including endosomes, and in the cytosolic 
uptake of the transport systems, with little correlation between the two. Also, we found significant 
differences between the cell lines. In general, protein transport systems based on cell-penetrating 
peptides show a modest total uptake, and mostly do not deliver cargo to the cytosol. Systems based 
on bacterial toxins show a modest receptor-mediated internalization but an efficient delivery to the 
cytosol. Supercharged proteins, on the contrary, are not receptor-specific and lead to massive total 
internalization into endosomes, but only low amounts end up in the cytosol.
In general, cells do not permit access of polar macromolecules such as proteins or nucleic acids to their cytosol, 
and phospholipid membranes constitute an effective barrier. Nonetheless, over the years a number of systems 
have been reported to give cytoplasmic access to biomacromolecules, most notably cell-penetrating peptides1,2, 
supercharged proteins3,4, and bacterial toxins5,6. Many other, often non-protein based systems, including many 
different types of nanoparticles, have been reported to be capable of this as well7–9. A confounding feature espe-
cially of mammalian cells is their ability of endocytosis, which makes a clear distinction between endosomal and 
cytosolic localization of the taken-up molecules very critical.
However, up to this point, an objective comparison of the efficiency of cytosolic delivery of different transport-
ers is lacking. The main reason is that a quantitative comparison of the fraction of delivered cargo that reaches the 
cytosol, as opposed to being sequestered in endosomes, has been difficult to achieve. Recently, we showed that it 
is possible to use a biotin ligase (BirA) assay for the objective quantification of cytosolic delivery6. The principle 
of the assay is that a 15-amino-acid tag, the avi tag, will become biotinylated when it encounters the prokaryotic 
BirA, which is exclusively overexpressed in the cytosol of the reporter cell lines6 (Fig. 1a). Importantly, the avi tag 
is not a substrate of endogenous eukaryotic biotin ligases. Biotinylation of an overexpressed avi-tagged protein 
was always 100% in the presence of a very high continuous production, with never any unbiotinylated protein 
detectable in the steady state, demonstrating the high rate and high efficiency of the avi tag biotinylation in the 
presence of biotin ligase. A harsh lysis method ensures that no biotinylation activity occurs after lysis10. The 
assay is highly sensitive because of the extremely high affinity between biotin and streptavidin, which is used for 
detection in western blots, and which is furthermore a sensitive method in general. The assay can be used for the 
detection of amounts that reflect cytosolic concentrations from low nanomolar to high micromolar. The quanti-
tation gives a linear response over a wide range6. In some cases the lower detection limit can be compromised due 
to background signals from proteins that non-specifically interact with streptavidin, in which case an anti-biotin 
detection antibody can still be employed with higher specificity but lower sensitivity6.
The unique features of the BirA assay have enabled us to conduct the present study, in which we compare 
the total cellular internalization and cytosolic delivery of a variety of protein uptake systems that have been 
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extensively characterized and assessed for cellular delivery, but which had never been quantitatively compared 
with respect to their ability to achieve cytosolic delivery. Importantly, the current methodology is the only availa-
ble method that allows the determination of total cellular internalization and cytosolic delivery in parallel, using 
only a single method and in a generic fashion, thus ensuring a high comparability and broad applicability.
Results
Uptake systems investigated. The systems were based on two classical cell-penetrating peptides: tat and 
penetratin11,12; three well-studied bacterial toxins: Pseudomonas exotoxin A, anthrax toxin and diphtheria toxin13–15  
and the prototypical supercharged protein, supercharged GFP (scGFP)3. As a model cargo, we took the small con-
sensus designed ankyrin repeat protein (DARPin) NI1C, which is a non-selected binding protein of intermediate 
thermodynamic stability with a melting temperature of 60 °C and a size of 11 kDa16. The study was designed to 
investigate the steady-state levels that can be reached by different protein transporters in different cell lines. We 
focused on a single 20 h time-point, as all vectors will have reached steady-state levels by then (see below).
The uptake systems differ significantly in their uptake mechanisms. At low concentrations, the cell-penetrating 
peptides tat and penetratin predominantly enter cells via distinct endocytic routes and stay in the endolysosomal 
system, while at higher concentrations, a direct plasma membrane translocation, especially of cationic peptides, 
becomes more pronounced17–19. The prototypical cell-penetrating peptides tat and penetratin do not rely on a 
receptor and are therefore not considered cell-specific20.
In contrast, virtually all bacterial toxins do contain a protein domain that is responsible for binding to a spe-
cific receptor. In the case of Pseudomonas exotoxin A, anthrax toxin and diphtheria toxin, the receptor-binding 
module can be exchanged for an alternative receptor-binding protein, thereby redirecting the uptake system 
specifically to a receptor of choice6,21–23. The redirected toxin will then be internalized via the endocytic pathway 
that is associated with the internalization of this particular receptor, before delivering the cargo to the cytosol. It 
is often unclear how much of the internalized cargo truly reaches the cytosol.
Similar to cell-penetrating peptides, multiple endocytic routes have been found to play a role in the inter-
nalization of supercharged proteins, predominantly clathrin-mediated endocytosis and macropinocytosis24. 
Figure 1. The biotin ligase assay and protein uptake system components. (a) Schematic representation of the 
biotin ligase assay. (b) A non-selected DARPin with an avi tag was expressed in the cytosol of SKBR3 cells stably 
overexpressing prokaryotic biotin ligase. The lysate was either pre-incubated with streptavidin (+) or not (−) 
before being probed using anti-DARPin serum by western blotting. The biotinylated protein is symbolized 
by a grey circle, biotin by an orange circle, and tetrameric streptavidin by red circles. The blot image has been 
cropped for conciseness. The full-size blot is presented in Supplementary Fig. 5. The four cell lines, which were 
modified to stably overexpress biotin ligase, are listed. (c) Schematic structural models of the components of 
the transporter-cargo fusion proteins that were assessed for cytosolic delivery in this study. Not drawn to scale. 
From left to right, crystal structures used were PDB ID: 1IKQ for Pseudomonas exotoxin A51, PDB ID: 1MDT 
for diphtheria toxin52, PDB ID: 1ACC for anthrax protective antigen53, PDB ID: 1J7N for lethal factor54, PDB 
ID: 1EMA for green fluorescent protein55 and PDB ID: 2XEE for the designed ankyrin repeat proteins56. The 
structure of the model cargo NI1C is a model generated by removing two of the three internal repeats from the 
structure of the full consensus DARPin with three internal repeats (PDB ID: 2XEE). DARPin, designed ankyrin 
repeat protein. EpCAM, epithelial cell adhesion molecule. Diphtheria toxin (1-389) contains the mutation 
G79D inactivating the catalytic activity.
www.nature.com/scientificreports/
3Scientific REPORts | 7: 13194  | DOI:10.1038/s41598-017-13469-y
Supercharged proteins accumulate mostly in endosomes, as reflected by a punctate fluorescence pattern, even 
though access of delivered cargo to the cytosol has been reported as well25.
EpCAM as a model receptor. In this study, all receptor-targeted constructs were directed to the epithelial 
cell adhesion molecule (EpCAM). EpCAM is a cell surface receptor that has often been used for targeted drug 
delivery, and that is known to lead to rapid internalization after binding26,27. EpCAM-mediated internalization 
has been shown to be very sensitive to the clathrin-mediated endocytosis inhibitor chlorpromazine, thereby iden-
tifying clathrin-mediated endocytosis as the main route of entry28. This strong reliance on a single uptake route 
is different from what has been seen for cell-penetrating peptides and supercharged proteins, which can exploit 
multiple mechanisms at the same time17,24. The requirement of available EpCAM for high-affinity binding and a 
specific route of uptake would suggest that the receptor-mediated internalization would be more active at lower 
concentrations, but would show signs of saturation. Most importantly, the pivotal role of the surface receptor also 
makes uptake specific for cells carrying this receptor, rendering import potentially tissue specific.
Choice of cell lines studied. Here, the uptake was investigated in four cell lines expressing EpCAM, which 
have all been stably transduced to overexpress the reporter protein BirA: MCF7, SKBR3, HT29 and Flp-In 293 
(the latter has been constructed to stably overexpress EpCAM6) (Fig. 1b, Supplementary Fig. 1). The complete 
and rapid biotinylation of cargo molecules was determined for Flp-In 293, MCF7 and SKBR3 cells through over-
expression of an HA- and avi-tagged DARPin in the cytosol. After continuous expression of the DARPin for 24 h, 
cells were lysed and the degree of biotinylation was assessed through a gel retardation assay, where the DARPin 
is incubated with streptavidin before loading. For all three cell lines, despite high levels of biotinylated DARPins, 
virtually no unbiotinylated DARPins could be detected (which would remain at its original molecular weight and 
not co-migrate with streptavidin), indicating that biotinylation is essentially complete under these steady-state 
conditions.
To investigate how rapidly biotinylation occurs in the cytosol, we also investigated the degree of biotinylation 
after shorter periods of cytosolic expression. As soon as cytosolic protein could be detected by western blotting 
(after 8 hours in Flp-In 293 BirA and MCF-BirA cells, probably mostly reflecting the time of DNA uptake, but also 
transcription and translation), all of the detected protein was fully biotinylated as well (Supplementary Fig. 2). We 
thus conclude that the biotinylation of avi tags is not rate limiting, and must be rapid. If biotinylation were slow 
(only occurring >15 min after production), then some level of an unbiotinylated band of the freshly produced 
DARPin would have been observed in growing cells.
We aimed to provide general insights into the behavior of protein uptake systems, not only in the Flp-In 293 
reporter cell line that we previously developed, but also in cancer cell lines with different characteristics. Hence, 
the main criterion for choosing the cell lines was, next to the fact that they need to express both EpCAM and 
BirA, that they were sufficiently distinct from each other, so that we cover a wider range of potential similarities 
and differences. MCF7 and SKBR3 cells are both breast cancer cell lines: MCF7 is classified as a luminal A subtype 
and SKBR3 is classified as HER2-positive subtype29. HT29 is a colorectal adenocarcinoma line and the Flp-In 293 
cell line is a human embryonic kidney (HEK) 293-derived cell line modified for ease of creating stable cell lines 
by recombineering. As mentioned, all cell lines were EpCAM positive, since we wanted to take receptor-mediated 
uptake and subsequent delivery to the cytosol into consideration. Furthermore, this would also investigate the 
possibility of being able to obtain cell-type specific cytosolic delivery via the presence or absence of a surface 
receptor.
In our previous study, we focused on Flp-In 293 cells and to a lesser extent on MCF7 cells6, but others have also 
provided numerous reports on the successful redirection of the bacterial toxins Pseudomonas exotoxin A, anthrax 
toxin and diphtheria toxin towards a variety of protein receptors in all of the four cell lines from the present panel, 
but comparisons are lacking14,30–34. Similarly, cell-penetrating peptides have been extensively studied over the last 
20 years, and many reports of tat and penetratin as well as fusions thereof have been studied in HEK293, MCF7, 
SKBR3 and HT29 cells, but also here the results are difficult to compare35–38. Supercharged proteins have been 
less widely studied, though it has been proposed that they can internalize into endosomes in most mammalian 
cells through interaction with sulfated proteoglycans. Cells that produced only non-sulfated proteoglycans were 
incapable of efficient uptake of supercharged proteins3. Importantly, to this date there exists no study in which 
comparisons between the different classes of transporters have been reported.
Protein components of the uptake systems. An overview of the components of the tested protein 
uptake systems is given in Fig. 1c. Distinct purification strategies were followed for different proteins, depending 
on the properties of the protein to be purified and on previously established purification protocols. A schematic 
overview of the purification strategies is given in Fig. 2. The final purity of the proteins was always assessed by 
Coomassie blue staining and, with the exception of penetratin-NI1C, all proteins were considered to have a purity 
greater than 90% (Fig. 3). The various combinations that were tested are schematically represented in Fig. 4. 
A representative chromatogram of a cation-exchange chromatography step, used for the purification of super-
charged proteins, is given in Supplementary Fig. 3.
Experimental conditions chosen. We chose protein concentrations from 200 nM up to 5 μM in the cel-
lular uptake assays, based on the delivery efficiencies of the various uptake systems obtained from preliminary 
studies. Uptake in Flp-In 293 cells was assessed after 20 h and after 4 h in the presence of proteasome inhibitor 
(Figs 5 and 6). Uptake in MCF7, HT29 and SKBR3 cells was assessed only after 20 h (Fig. 6). Several combinations 
of concentrations and constructs that were not tested across all cell lines are given in the Supplementary Table 1 
and are specifically referred to in the text.
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We chose 20 h as a time-point because the purpose of the experiment was to investigate the steady-state levels 
that can be reached with these transport systems, rather than the uptake kinetics. In particular the Pseudomonas 
Figure 2. Schematic overview of the purification strategies for the fusion proteins used in uptake experiments. 
The numbers in the green boxes refer to the numbering system from Fig. 4. § The final purity of #5 was 
estimated to be ~70%, due to a co-purified degradation fragment (see Fig. 3). * 11 and 12 are binary 
toxins with two individually produced components. DT, diphtheria toxin; ETA, Pseudomonas exotoxin A; 
IMAC, immobilized metal-ion affinity chromatography; scGFP, supercharged GFP; SEC, size-exclusion 
chromatography; TEV protease, Tobacco Etch Virus protease.
Figure 3. Coomassie blue-stained gels showing the purity of the investigated cargo proteins. The numbering 
system is according to Fig. 4. Please note that 11 and 12 reflect binary toxins and consist of two proteins. Except 
for protein #3 (penetratin-NI1C), all proteins were considered to have a purity > 90%. To compensate for the 
lower purity of #3 (~70%), this protein was tested at higher concentrations as well (5 μM). The juxtaposition of 
lanes from the same gel that were originally non-adjacent is indicated through black vertical lines. Ac2 and Ec1, 
designed ankyrin repeat proteins recognizing EpCAM; DT, diphtheria toxin; ETA, Pseudomonas exotoxin A; LF, 
lethal factor; MBP, maltose-binding protein; NI1C, consensus designed ankyrin repeat protein; PA, protective 
antigen; sAntrx, soluble anthrax receptor domain; scGFP, supercharged GFP.
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exotoxin A (ETA)-based constructs had previously been shown to have rather slow uptake kinetics39, but we 
reasoned that after 20 h, all transport systems would have reached a steady-state level. To support this hypothesis, 
we compared the cytosolic uptake of Ec1-ETA(252–412)-NI1C (a Pseudomonas exotoxin A-based construct) and 
LF-NI1C + PA-Ac2 (an anthrax toxin-based uptake system) as a function of time (Supplementary Fig. 2). Indeed, 
while the uptake of LF-NI1C was somewhat more rapid, reaching maximum levels after 4 h but little decline after 
20 h, cytosolic levels of Ec1-ETA(252–412)-NI1C only became high after 20 h.
The 4 h time point in Flp-In 293 cells in the presence of proteasome inhibitor was included to investigate deliv-
ery to the cytosol without the confounding effect of rapid proteasomal degradation. In the 20 h experiments it was 
not possible to include proteasome inhibitors due to toxicity of long-term proteasome inhibition.
Principles of measuring total internalization vs. cytosolic uptake. Western blot data from a rep-
resentative uptake experiment in Flp-In 293 cells using several of the tested protein uptake systems are given in 
Fig. 5, with the boxes indicating the bands that were used for determining cellular uptake. Total cellular inter-
nalization, reflecting the sum of the uptake in endosomes and cargo delivered to the cytosol, was determined 
by the HA tag (Fig. 6, cf. Figure 1a). It must be emphasized that only the total cellular uptake of fully intact 
proteins is being detected. The data are given as concentrations in the cell at the time of lysis. We calculated this 
from the number of cells at the time of lysis, the experimentally estimated volume of the cells and the quantity 
of the protein detected by western blot, in turn determined with a calibration standard of a fully biotinylated 
and HA-tagged protein, loaded as a control on each one of the western blots. The protocol is summarized in the 
Methods section, and more extensively explained in a recent methods paper10.
Cytosolic delivery was assessed quantitatively on western blots using fluorescently labeled streptavidin and 
data are represented as cytosolic concentrations, using the same method as for calculating total cellular inter-
nalization (Fig. 6). For ease of comparison, the cytosolic volume was taken to be the same as the total cell vol-
ume. Anti-actin and anti-DARPin western blots were included for assessing fair loading and protein degradation, 
Figure 4. Numbering and block structures showing the modules of the cargo proteins that were assessed 
in this study. Note that # 11 and # 12 represent delivery systems based on binary toxins and thus encompass 
two separate components. DT, diphtheria toxin; ETA, Pseudomonas exotoxin A; LF, anthrax lethal factor; PA, 
anthrax protective antigen; pen, penetratin; santrx, soluble anthrax receptor domain; scGFP, supercharged 
green fluorescent protein.
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respectively. The polyclonal anti-DARPin serum is less suited for the determination of absolute concentrations, 
because the quantitative recognition of the epitopes may be DARPin-dependent and because several of the inves-
tigated uptake systems contain both a DARPin targeting EpCAM as well as a DARPin cargo. Nevertheless, in 
situations where degradation of the C-terminal HA tag employed for detection occurs (see below), the use of the 
DARPin signal can provide important insights into the fate of the transporter and its cargo. In instances where 
both total cellular internalization and significant cytosolic uptake could be measured, the fraction of intact inter-
nalized cargo that reached the cytosol was assessed (Supplementary Table 2).
Total cellular internalization (i.e., endosomes + cytosol). Similar uptake patterns could be discerned 
across multiple cell lines, and we focus first on total cellular internalization (i.e., endosomes + cytosol) for the 
various constructs, without making a distinction about these two different compartments (Fig. 6a,c,e,g,i). Total 
cellular internalization was extremely high for supercharged GFP (scGFP) variants in all cell lines, presumably 
because of a very efficient, receptor-independent interaction of the highly positively charged proteins with the 
negatively charged plasma membrane, especially the negatively charged oligosaccharides exposed to the out-
side milieu, leading to massive amounts of endocytosis. Already at an external concentration of 200 nM, the 
average total cellular concentration of scGFP fusions that we determined ranged from 1.7 μM (scGFP) to 23 μM 
(Ec1-scGFP) in HT29 cells, from 2.9 μM (scGFP-NI1C and Ec1-scGFP) to 6.3 μM (scGFP) in SKBR3, from 0.9 μM 
(scGFP-NI1C) to 2.9 μM (scGFP) in MCF7 cells and from 2.9 μM (scGFP) to 15 μM (scGFP-NI1C) in Flp-In 293 
cells. No clear effect on uptake was observed for the presence of the EpCAM-targeting protein Ec1, though uptake 
in HT29 tended to be higher for Ec1-scGFP than for scGFP and scGFP-NI1C. Notably, in HT29 cells, there was 
very evident toxicity at 1 μM for all of the supercharged GFP constructs. In the other cell lines, significantly higher 
uptake levels were observed at 1 μM than at 200 nM, reaching up to an average of 66 μM in Flp-In 293 cells for 
scGFP (Supplementary Table 1). The higher uptake levels at higher concentrations indicate the absence of any 
saturatable uptake process for supercharged GFP and fusions thereof.
Total cellular internalization was much lower or even below the detection level for uptake systems based on 
cell-penetrating peptides and bacterial toxins that were targeted to EpCAM. For cell-penetrating peptide-only 
fusions (i.e. without a bacterial toxin domain or an EpCAM-targeting DARPin), at an external concentration of 
200 nM, total cell concentrations ranged from being undetectable in HT29, SKBR3 and MCF7 cells to 34 nM for 
Figure 5. Example western blot of a 4-hour uptake experiment of various protein uptake systems in Flp-In 293 
cells. The numbering system is according to Fig. 4. The blot images have been cropped for conciseness. The full-
size blots are presented in Supplementary Fig. 5.
www.nature.com/scientificreports/
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Figure 6. Uptake of various systems in biotin ligase-overexpressing cells. The numbering system is according 
to Fig. 4. Concentrations are indicated for the respective conditions. LF-cargo fusions were used at 0.2 μM; PA 
fusions at 20 nM. Quantification of total cellular (a,c,e,g,i) and cytosolic uptake (b,d,f,h,j) of 4-hour (Flp-In 
293) and 20-hour (all) uptake experiments in the indicated cell lines. Data points reflect absolute concentrations 
that were present in either the “total cell” or “cytosol” at the time of lysis, calculated using knowledge on the cell 
number, cell volume and a reference protein, as described in detail in the Methods section. All data points are 
derived from fully independent experiments. If no data points are shown, no protein could be detected. The 
horizontal line represents the average. * due to band overlap with an endogenously biotinylated species in the 
cell line, the cargo LF-NI1C was replaced with LF-NI2C-dest.5, which has a MW that is 3.4 kDa higher but 
possesses similar delivery characteristics6.
www.nature.com/scientificreports/
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penetratin-NI1C in Flp-In 293 cells. In general, there was a correlation between higher external concentrations 
and higher uptake levels, without any evidence of saturation. This is expected for cell-penetrating peptide fusions, 
and thus similar to the supercharged proteins. At 1 and 5 μM external concentrations, total levels increased to an 
average of 67 nM and 588 nM, respectively, for penetratin-NI1C in Flp-In 293 cells. At 5 μM penetratin-NI1C in 
the medium, a total internal concentration in MCF7 cells of 30 nM was found, in HT29 of 43 nM and in SKBR3 
of 149 nM. Tat-NI1C was essentially undetectable, except at 5 μM external in SKBR3 cells (5.4 nM) and HT29 
cells (6.2 nM). Strikingly, after 4 h in the presence of proteasome inhibitor in Flp-In 293 cells, both tat-NI1C 
and penetratin-NI1C were detectable at all external levels tested (200 nM, 1 and 5 μM), giving average values of 
14 nM, 16 nM and 118 nM (tat-NI1C) and 45 nM, 115 nM and 309 nM (penetratin-NI1C) (Fig. 6a; Supplementary 
Table 1). Adding the EpCAM binder Ec1 to the fusion between the cell-penetrating peptide tat and NI1C only 
yielded a benefit in MCF7 cells, where at 1 μM the fusion tat-Ec1-NI1C, but not tat-NI1C or Ec1-NI1C gave a 
detectable signal (18 nM). Besides the scGFP fusions, where uptake is independent of the EpCAM-targeting 
DARPin Ec1, this was the only occurrence where an Ec1 fusion was detected in MCF7 cells.
Fusion proteins containing bacterial toxins and the EpCAM-targeting domain and/or the cell-penetrating 
peptide tat performed well in Flp-In 293 cells with respect to total internalization: the Ec1-DARPin ETA fusion 
gave better results than the tat-ETA-NI1C fusion, as the latter only reached detectable levels at 1 μM. Notably, the 
EpCAM-DARPin Ec1 fused to NI1C was also detected at high levels, indicating high levels of EpCAM. In HT29 
cells, bacterial toxin-domain systems performed less well, but were in several instances still detectable via the 
HA tag: a fusion between tat and ETA-NI1C and fusions between diphtheria toxin and anthrax toxin systems 
and the EpCAM binder Ac2 were still detected (Fig. 6g). This was not the case in MCF7 or SKBR3 cells, again 
indicating either only moderate EpCAM levels or a high proteolytic activity causing cleavage of the HA tag. In 
contrast to cell-penetrating peptide- and scGFP-fusions, for toxin-based constructs, total internalization was not 
or not much higher at 1 μM than at 200 nM. Also in view of the high affinity of the EpCAM-targeting DARPins 
(61 pM for Ec1 and 1.2 nM for Ac240), this indicates an almost full saturation of the receptor-mediated endocytic 
internalization at 200 nM (Fig. 6a,c,g).
Delivery to the Cytosol. The quantity of greatest interest, delivery to the cytosol, followed a strikingly 
different pattern compared to total internalization (Fig. 6b,d,f,h,j). For the fraction of the internalized cargo 
that reached the cytosol (Supplementary Table 2), the calculations yielded values higher than 100% in multiple 
instances, effectively meaning that more biotinylated protein was detected than HA-tagged protein. Furthermore, 
there were a number of cases where HA-tagged proteins could not be detected, whereas biotinylated proteins 
could. Since anti-DARPin signals were detected in such instances (Supplementary Fig. 4 and Supplementary 
Table 3), this is presumably due to cleavage of the HA tag, as described before6,41. The higher sensitivity of the 
biotin-streptavidin interaction, as compared to the HA-antibody interaction, may play a role as well6. A possible 
cleavage of the HA tag is not an inherent limitation of the biotin ligase assay, as the HA tag can in principle be 
exchanged for any other tag. Since in the present study the HA tag was positioned behind the avi tag, its cleav-
age is certainly possible, and would lead to apparent fractions of cytosolic cargo that exceed 100%. To avoid 
confusion, we listed the apparent fraction for these cases as >100%. To provide further insight into the delivery 
process, we estimated the total cellular internalization in some instances additionally through the anti-DARPin 
antibody. Quantitation in this case is less straightforward since the antibody is polyclonal, and in some instances 
two DARPins reside in the same protein transport system.
The control construct that consisted of the EpCAM-targeting moiety Ec1 directly fused to the cargo NI1C, not 
containing any transport domain, showed good receptor-mediated internalization into endosomes in Flp-In 293 
cells, but no delivery into the cytosol, as expected. Both transporters based on Pseudomonas exotoxin A (ETA) 
and anthrax toxin yielded detectable levels in HT29 cells (Fig. 6h) and performed well in Flp-In 293 (Fig. 6b,d), 
with average levels of 5.8 nM for Ec1-ETA-NI1C and 7.1 nM for the anthrax toxin-based construct (#12) in HT29 
cells, and 1.4 μM and 49 nM for the same constructs in Flp-In 293 cells, all at an external concentration of 200 nM. 
The fraction delivered to the cytosol would be calculated as 52% to more than 100% for the anthrax toxin-based 
construct and appeared >100% for Ec1-ETA-NI1C, presumably all due to HA tag cleavage, as explained before. 
Also here, the higher levels in Flp-In 293 cells are likely a consequence of the high levels of EpCAM, as well as 
the high efficiency of cytosolic delivery of the ETA construct in Flp-In 293 cells. In this cell line, uptake was also 
assessed after 4 h in the presence of proteasome inhibitor. Levels of Ec1-ETA-NI1C and the anthrax toxin-based 
construct were similar to those at 20 h, with average values of 1.0 μM and 85 nM, respectively, indicating no 
major effects of proteasomal degradation for these transporters. The apparent fraction delivered to the cytosol 
appeared again >100% for the ETA-based constructs across many conditions, and ranged from 11% to 28% for 
the anthrax-based constructs in Flp-In 293 cells.
In MCF7 cells, only the toxin-based systems that incorporated an ETA translocation domain resulted in a 
good cytosolic delivery. Also in this cell line, the highest delivery was observed for Ec1-ETA-NI1C with average 
levels of 40 nM and 59 nM at 200 nM and 1.0 μM, respectively. No HA-tagged proteins were detected under these 
conditions but good anti-DARPin signals were detected in this cell line, indicating HA tag cleavage. Since in 
Flp-In 293 cells good signals for both HA and anti-DARPin signals were observed after 20 h for similar constructs, 
this indicates that the rate of HA tag cleavage is mainly cell-specific, and not construct-specific (Supplementary 
Table 4). Furthermore, no increase in degradation over time was observed in Flp-In 293 cells, when ratios after 
4 and 20 h were compared (Supplementary Table 4). Importantly, the fact that HA tag cleavage is a cell-specific 
phenomenon means that valid comparisons of constructs within a single cell line can be done.
It is in principle possible to perform a similar calculation of total cellular uptake using anti-DARPin signals, of 
which the results from MCF7 cells for three proteins are given in Supplementary Table 3, even though estimations 
should be interpreted with caution because of the polyclonal nature of the anti-DARPin signal. For the diphtheria 
toxin-based constructs, where no cytosolic uptake was detected, total uptake values varied between 11 and 40 nM 
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at external concentrations of 200 nM and 5 μM, respectively. For the two ETA-based constructs, total uptake levels 
varied between 30 and 110 nM, and were similar to what was observed for the cytosolic uptake, again confirming 
that a very large fraction of internalized ETA protein reaches the cytosol in MCF7 cells.
In MCF7 cells, the tat functionality did not lead to any cytosolic uptake, remaining the same as the control 
devoid of any uptake system (ETA-NI1C), and tat even decreased the total cellular uptake in the presence of the 
EpCAM binder Ec1, as assessed via the anti-DARPin serum signal. Surprisingly, in SKBR3 cells, none of the 
cell-penetrating peptide fusions nor any toxin domain fusions yielded detectable cytosolic levels. The latter could 
be either due to a high proteolytic activity towards the tags that have to be detected, to rather modest levels of 
EpCAM, or to a slower internalization rate of EpCAM in this particular cell line.
The diphtheria-based construct did not achieve efficient transport to the cytosol of NI1C in HT29, MCF7 or 
SKBR3 cells, even though low amounts of cytosolic delivery could be detected in Flp-In 293 cells, both after 20 h 
(158 nM at 5 μΜ) and after 4 h (24 nM at 5 μM external concentration) in the presence of proteasome inhibition 
(Fig. 6b,d).
Cytosolic delivery of cell-penetrating peptide fusions, without the presence of an ETA domain, was undetecta-
ble in HT29, MCF7 and SKBR3 cells. Only in Flp-In 293 cells could the penetratin-NI1C fusion be detected at the 
highest levels tested, 5 μM. Here, an average cytosolic concentration of 38 nM was detected, estimated to indicate 
that between 2 and 5% of internalized cargo has reached the cytosol. In contrast to what was observed for toxin 
domain fusions, fusions between NI1C and cell-penetrating peptides performed markedly better after 4 h in the 
presence of proteasome inhibitor as compared to after 20 h, with average levels of 71 and 92 nM for tat-NI1C and 
penetratin-NI1C at 5 μM, respectively, but also giving detectable levels for both fusions at 1 μM (4.5 nM – 39 nM) 
and 200 nM (7.8 nM – 25 nM). This indicates that at least part of the low efficiency observed may be due to a poor 
cytosolic stability.
Despite the massive total cellular internalization, scGFP-based constructs showed little delivery to the cytosol 
or none at all, indicating a poor endosomal escape efficiency. In MCF7 cells, at 200 nM only scGFP without cargo 
was detected, but this was at the comparably low level of 21 nM, which corresponded to only 0.2–0.4% delivery to 
the cytosol (Fig. 6f). Levels in HT29 were similarly low, with average values of 16 nM at an external concentration 
of 200 nM (Fig. 6i), with calculated fractions of cytosolically delivered cargo between 0.5% and 1.1%. Also in 
Flp-In cells and SKBR3 cells, the cytosolic fractions were low and ranged from 0.7% – 7.5% (Flp-In 293) and 0.3% 
– 0.7% (SKBR3). These numbers are in stark contrast to what was observed for toxin-based protein transporters, 
where the apparent delivered cargo often was higher than 100%. It must be noted, however, that in the case of 
SKBR3 cells, cytosolic delivery could only be detected with scGFP, and not with cell-penetrating peptide or toxin 
domain fusions. Normally, scGFP would not be the sole cargo itself but would to be used to deliver another pro-
tein, and thus fusion proteins need to be investigated. In MCF7 and Flp-In 293 cells, coupling of scGFP to either 
a cargo (NI1C) or a receptor-targeting agent (Ec1), both adding negative charges to the construct, negatively 
influenced the ability to escape the cytosol (Fig. 6b,d,f), even though this was not evident in HT29 and SKBR3 
cells (Fig. 6h,j).
Through the use of an HA-tagged and biotinylated recombinant protein as a reference and knowledge about 
the cell number and volume, we could estimate absolute concentrations present in the cytosol. Determined levels 
ranged from low nanomolar to low micromolar, with especially high concentrations found in the Flp-In 293 cells 
that artificially overexpressed EpCAM. In the present study, values were expressed as absolute cellular concen-
trations, but a conversion to molecules per cell using the cell volumes that were measured in this study (2.9 pL 
for HT29 cells, 7.2 pL for MCF7 cells, 2.2 pL for Flp-In 293 cells and 4.4 pL for SKBR3 cells) are straightforward, 
leading to values ranging from the lower detection limits of ~38,000 molecules/cell (8.8 nM) up to ~258,000 
(59 nM) in MCF7 cells, from ~4,500 (3.6 nM) to ~3,280,000 (2.7 μM) in Flp-In 293 cells, from ~7,800 (4.5 nM) to 
~247,000 (143 nM) in HT29 cells and from ~63,000 (23 nM) to ~613,000 molecules/cell (223 nM) in SKBR3 cells.
Discussion
The sensitive, generic and objective nature of the biotin ligase assay has allowed the acquisition of data that clearly 
demonstrate that endosomal uptake does not correlate with delivery into the cytosol. The assay thus differenti-
ates the different systems regarding both quantities. Our data show that endosomal uptake can be achieved with 
cell-penetrating peptides, with a receptor-targeting moiety or via supercharged proteins. In contrast, endosomal 
escape can be efficiently achieved only with bacterial toxin-based protein transporters, which appear to have 
evolved for this purpose, but not or only poorly with fusions to cell-penetrating peptides or supercharged pro-
teins (Fig. 6). Moreover, CPP and scGFP lack cell specificity in endocytosis. Therefore, to bring CPP or scGFP 
fusions and their cargoes efficiently into the cytosol, further modifications would be necessary for them to be 
transported into the cytosol from the endosomes. Particularly for cell-penetrating peptides, various strategies 
are currently being investigated to achieve this, e.g. incorporation into branched systems or the combination 
with endosome-disrupting peptides or alternative endosome-disrupting moieties42,43, with novel strategies con-
tinuously being explored44,45. Also for supercharged proteins, the lack of cytosolic delivery has been previously 
been recognized and a peptide was recently identified that could enhance the endosomal escape severalfold46. 
Nonetheless, their lack of specificity for the cell type is an intrinsic feature of this charge type interaction, poten-
tially limiting their in vivo use.
Our investigations were performed in a panel of four different cell lines, which were chosen to reflect the 
variety in how cells deal with uptake systems. Despite a number general trends, we did observe large differ-
ences between the cell lines. Factors that are likely to affect the differences are many, and include the amount of 
EpCAM present on the cell surface, their endolysosomal protease activity, the amount of furin present (needed 
for processing of the bacterial transport systems) and the degradative activities present in the cytosol (limiting 
the steady-state levels), of both the entire cargo and/or the HA tag specifically. The large variety highlights the 
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challenges in developing a cytosolic protein delivery approach that works in many cell lines, including primary 
cell lines.
Whether protein-protein interactions can be inhibited through delivered binding proteins using the systems 
tested here will depend on the protein in question, as protein abundances are known to vary widely over many 
orders of magnitudes, from as low as 125 molecules per cell to >1 million per cell47. For many targets, the levels 
reached would be sufficient, as are the achievable binding affinities. It should be pointed out, however, that for 
most applications delivery will have to take place in more challenging environments, where delivery will be lower, 
implying that further improvements for all systems are still highly desirable.
In this study, we looked at steady-state levels that the transport systems might reach, which is of course of key 
importance when protein delivery is used as a tool either for fundamental research or for therapy. Nevertheless, 
a limitation of this study is that we only looked at a single time-point. It is known that transporters have different 
kinetics (cf. Supplementary Fig. 2), with the entry of cell-penetrating peptides and supercharged proteins par-
ticularly rapid3,48, whereas internalization via bacterial toxin-derived components can be slower, in particular for 
Pseudomonas exotoxin A-based systems39. It is therefore possible that due to (extracellular) degradation activity, 
in particular of unstructured cell-penetrating peptides, the levels for cell-penetrating have been lower than what 
would have been observed after shorter incubation times.
In conclusion, for many years, endosomal escape has been named as a major bottleneck in the delivery of 
macromolecular cargo such as proteins to the cytosol49,50. Here, we confirm and extend this notion by providing 
objective quantitative insights into this process for a small model cargo using a method that can be transferred 
to any cargo of interest, and we contrast this with uptake via protein toxins which have evolved for this purpose.
Methods
Cell culture. Flp-In 293 cells overexpressing EpCAM and BirA and HT29-BirA cells were maintained in 
DMEM supplemented with 10% fetal calf serum (FCS; Amimed). 1000 μg/mL G418 was included for HT29-BirA 
cells. MCF7-BirA cells were maintained in a HAM/DMEM mix (50:50) supplemented with 10% FCS and 400 μg/
mL G418. SKBR3-BirA cells were maintained in RPMI supplemented with 10% FCS and 200 μg/mL G418. All 
media were supplemented with 100 IU/mL penicillin and 100 μg/mL streptomycin (Sigma). All cell lines were 
tested negative for mycoplasma contamination.
Generation of stable BirA cell lines. Flp-In 293 cells were purchased from Invitrogen, HT29 cells from 
DSMZ (Deutsche Sammlung von Mikroorganismen and Zellkulturen) and SKBR3 and MCF7 cells were pur-
chased from ATCC (American Type Culture Collection). All cell lines were obtained in their original state, i.e. 
without genetic modifications. The generation of the Flp-In 293 cell line stably overexpressing EpCAM and BirA 
has been described before6. For MCF7, SKBR3 and HT29 stable cell line generation, a plasmid containing a 
cytomegalovirus promoter-driven birA, followed by an encephalomyocarditis virus (EMCV) internal ribosomal 
entry site (IRES) and neomycin resistance gene, was constructed by cloning the complete E. coli birA gene in the 
pCMV-EMCV-NEO vector (kind gift of Dr. J. Piehler, University of Osnabrück). A clonal dilution was made and 
single-cell-derived colonies were obtained in the presence of 400 μg/mL (MCF7) or 200 μg/mL (SKBR3) G418. 
Stable pools, continuously under selection with 1000 μg/mL G418, were obtained with HT29 cells. The activity 
of the biotin ligase-expressing cells was confirmed via the cytosolic overexpression of a DARPin or of a fusion of 
eGFP to the consensus DARPin NI3C16, in either case containing both an HA tag (YPYDVPDYA) and an avi tag 
(GLNDIFEAQKIEWHE)6 (Fig. 1b, Supplementary Fig. 1). The vector pcDNA3.1( + ) was used in both instances.
Biotin ligase uptake assay. Conditions during cellular incubations. Uptake experiments were exclusively 
performed with cell lines stably overexpressing biotin ligase. Briefly, cells were seeded in 24-well plates: 300,000 
cells per well for Flp-In 293 and HT29 cells and 150,000 for MCF7 and SKBR3. To check for biotinylation of the 
avi tag by the overexpressed biotin ligase, one well was transfected in each experiment with the cytosolically 
expressed non-selected DARPin E3_5, containing both an avi and an HA tag. For MCF7 and HT29 cells, the 
consensus DARPin NI3C fused to eGFP was used (avi-HA-NI3C-eGFP), also containing both an avi and HA tag, 
as the naked E3_5 DARPin resulted in only comparably low expression levels after 24 hours. Transfections were 
performed using TransIT-293 (Flp-In 293), TransIT-X2 (HT29) or TransIT-LT1 (MCF7 and SKBR3) using the 
manufacturer’s protocol (Mirus).
Proteins were diluted to the indicated concentrations in the same complete medium that was used for culti-
vating the cells, supplemented with 0.1 mM biotin (final concentration). When performing 4-hour incubations, 
the proteasome inhibitor MG-132 (Calbiochem, Merck Millipore) was added to a concentration of 50 μM in the 
medium. 400 μL of the prepared protein in complete medium was added to each well.
Lysis procedure. After the indicated incubation time, the medium was removed from the wells. All cells were 
washed once with 500 μL Dulbecco’s PBS (Sigma), except Flp-In 293 cells, which adhere only lightly and were not 
washed. Cells were detached by adding 100 μL trypsin-EDTA solution (Sigma) and incubated for approximately 
5 min at 37 °C. Subsequently, 800 μl fresh complete medium was added to the cells to dilute the trypsin. The 
mixture was then transferred into 1.5 mL microcentrifuge tubes. Cells were centrifuged at 300 × g for 3 min and 
resuspended in 800 μL Dulbecco’s PBS after removing the supernatant. The centrifugation step was repeated and 
excessive PBS was removed. Finally, the cells were lysed by resuspending the cell pellets in 50 μL hot (96 °C) SDS 
lysis buffer that was supplemented with 20 μM of a stabilized avi tag peptide6 and further heating the samples for 
8 min at 96 °C. The cells that were transfected with the control DARPin or DARPin-eGFP construct containing 
avi and HA tags were lysed with the same protocol. Before western blotting, the lysate was divided and diluted 
fourfold in a non-denaturing, non-reducing buffer (0.5 M Tris-HCl, pH 6.8, 20% (v/v) glycerol, 0.02% (w/v) 
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bromophenol blue), either containing streptavidin (concentration: 50 μg/mL) or not, and incubated for 2 h at 4 °C. 
Samples were stored at −20 °C until analysis by western blotting.
Western blotting. Western blotting was performed essentially as described previously6. Briefly, Immobilon-FL 
PVDF membranes (Merck Millipore) were pre-activated with MeOH and used for wet blotting for 1 h at 100 V. 
Blocking was accomplished with casein blocking buffer (Sigma) for 30 min at room temperature while shaking 
on a roller shaker. Then, the primary antibody solution in PBS with 0.1% (v/v) Tween-20 and 1 × casein blocking 
buffer (antibody incubation buffer) was applied on the blot and incubated for 1 h at room temperature while 
shaking on the roller shaker. The primary antibodies used were streptavidin-IRDye 680LT (LI-COR Biosciences), 
polyclonal rabbit anti-HA (H6908, Sigma-Aldrich), mouse anti-actin (ab8224, Abcam) and a home-made 
rabbit anti-DARPin serum. Secondary antibodies were goat anti-rabbit Alexa Fluor 680 (Invitrogen), donkey 
anti-mouse IRDye800 CW (LI-COR Biosciences) and goat anti-rabbit IRDye800 CW (LI-COR Biosciences). 
When incubating with the fluorescently labelled streptavidin (IRDye 680LT), also 0.1% (w/v) SDS was included 
to reduce non-specific binding of streptavidin. Blots were either incubated with streptavidin-IRDye 680LT and 
anti-DARPin serum together, or with the anti-HA and anti-actin antibodies together. Detection was accom-
plished using an Odyssey 9120 imaging system (LI-COR Biosciences).
Data analysis. Bands corresponding to the expected molecular weights were quantified using Image Studio 
Lite software for determining total cell (anti-HA) and for cytosolic (IRDye 680LT-labeled streptavidin) concen-
trations. This imaging method gives a highly linear signal range, which has been confirmed before6. Identical 
image acquisition settings were used for distinct blots within a single experiment. In some cases where excessive 
differences in signal intensities were observed (i.e. > 10,000 times higher in intensity for scGFP vs bacterial toxin 
constructs in total cell uptake), additional images were acquired at a lower intensity to avoid oversaturation issues. 
A loading control for calibration purposes was also present in these instances.
Bands were only quantified when they could be clearly identified as a separate band by eye and when they 
were not observed in an untreated sample (e.g. unspecific bands), which was included on every western blot. All 
conditions were investigated in two or three fully independent experiments (i.e. biological replicates). All indi-
vidual data points are shown for conditions where the band could be detected in at least two fully independent 
experiments.
To correct for differences in signal acquisition between blots and experiments, 0.50 pmol of a fully biotiny-
lated and HA-tagged protein was loaded on each blot as a calibration control (either Ec1-ETA(252–608)-NI3C, 
Ec1-ETA(252–412)-NI1C or LF-NI3C). To correct for the staining intensity with streptavidin-LT680 between 
blots in a single experiment, the strongest unspecific signal (which is independent of the cargo protein) was 
quantified in the first 10 wells containing cell lysate of each blot. This normalization protocol was chosen as it 
proved to be more accurate than using the streptavidin signal from the fully biotinylated protein. Signals from 
the HA-tagged and biotinylated reference protein (reflecting 0.5 pmol protein) were then used to calculate back 
the amount of HA-tagged and biotinylated cargo protein in the lysate. Since the number and volume of the cells 
in the 24-well plate was determined after each experiment with the CASY Counter (Roche), which calculates the 
cell volume based on electric current exclusions and pulse area analysis, the amount of protein in the lysate could 
be converted to the actual concentration in the cell or cytosol. An equal volume for cell and cytosol was assumed 
and the contribution of the nucleus was left out, which will lead to a moderate underestimation of the actual cyto-
solic concentration, but enhances the comparability of the results of “total cell” and “cytosol”, as it compares the 
number of molecules per cell. Note, however, that the actual volume of the endosomes is much smaller than the 
cell volume, such that the local concentration of a protein exclusively located in endosomes will be significantly 
underestimated.
Cloning, protein expression, protein purification and in vitro biotinylation. For details on the 
abovementioned procedures, please see the Supplementary Methods section.
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